Previous Close | 38.30 |
Open | 38.10 |
Bid | 38.31 x 48300 |
Ask | 38.33 x 51100 |
Day's Range | 38.17 - 38.33 |
52 Week Range | 32.74 - 48.36 |
Volume | |
Avg. Volume | 578,420 |
Market Cap | 8.737B |
Beta (5Y Monthly) | 0.43 |
PE Ratio (TTM) | 28.79 |
EPS (TTM) | 1.33 |
Earnings Date | N/A |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | Jan 25, 2017 |
1y Target Est | 47.90 |
Key Insights The projected fair value for Qiagen is US$36.75 based on 2 Stage Free Cash Flow to Equity Current share...
Seattle Genetics (SGEN) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
QIAGEN’s ForenSeq Kintelligence System recently used by DNA Labs International in the U.S. to solve unidentified remains case in Oregon and 51-year-old criminal investigation in Georgia // ForenSeq Kintelligence enables identification of distant relatives in genealogy databases, helping to resolve previously unsolvable cases and bringing answers to victims and families // DNA Labs International is one of the first labs to offer this new approach to human identificationVenlo, the Netherlands, and